Matinas BioPharma Holdings Inc Cash Flow-to-Debt Ratio
Matinas BioPharma Holdings Inc cash flow-to-debt ratio. Matinas BioPharma Holdings Inc (MTNB) has a Cash Flow-to-Debt Ratio of -0.56x as of March 2026, meaning its operating cash flow of $-1.60 Million could theoretically repay -1% of its total liabilities ($2.85 Million) in one year. See MTNB free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Matinas BioPharma Holdings Inc (2012–2025)
Cash flow-to-debt ratio of Matinas BioPharma Holdings Inc from 2012 to 2025. Historical debt coverage capacity for Matinas BioPharma Holdings Inc across 14 annual periods. Check cash flow reinvestment rate of Matinas BioPharma Holdings Inc to assess the company's total reinvestment commitment from operating cash flow.
Matinas BioPharma Holdings Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Matinas BioPharma Holdings Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Matinas BioPharma Holdings Inc. For the full cash flow conversion analysis, see Matinas BioPharma Holdings Inc (MTNB) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.95x | $-7.01 Million | $2.38 Million | ▲ +6.3% |
| 2024 | -3.14x | $-15.88 Million | $5.05 Million | ▼ -20.6% |
| 2023 | -2.61x | $-15.28 Million | $5.86 Million | ▼ -474.9% |
| 2022 | -0.45x | $-19.16 Million | $42.23 Million | ▲ +73.7% |
| 2021 | -1.72x | $-15.22 Million | $8.83 Million | ▲ +28.2% |
| 2020 | -2.40x | $-17.37 Million | $7.24 Million | ▼ -22.4% |
| 2019 | -1.96x | $-14.09 Million | $7.19 Million | ▲ +27.8% |
| 2018 | -2.72x | $-10.32 Million | $3.80 Million | ▲ +11.3% |
| 2017 | -3.06x | $-11.46 Million | $3.74 Million | ▼ -33.5% |
| 2016 | -2.29x | $-6.12 Million | $2.67 Million | ▲ +31.5% |
| 2015 | -3.35x | $-7.81 Million | $2.33 Million | ▲ +52.3% |
| 2014 | -7.02x | $-7.96 Million | $1.13 Million | ▼ -101.9% |
| 2013 | -3.48x | $-2.99 Million | $858.97K | ▼ -412.8% |
| 2012 | -0.68x | $-57.26K | $84.43K | — |